Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 70 results found. Search for [ Nilesh Gupta ]

Results 1 to 21 of 70
PTI
January 18, 2020
The USFDA inspection for the API facility at Vizag was carried out between January 13, 2020 and January 17, 2020, and it closed five 483 observations


Sonal Khetarpal
New Delhi, January 18, 2020
With the rise of e-commerce, retailers are now trying the omnichannel approach where their online and offline stores are integrated seamlessly to be present at all customer touch points


PB Jayakumar
January 14, 2020
A couple of days ago, Lupin said that it had received two observations from the US health regulator following the inspection at its Nagpur manufacturing facility, one of its most modern plants


PTI
January 11, 2020
A Prior Approval Inspection was carried out by the United States Food and Drug Administration at Lupin's Nagpur oral solid dosage manufacturing facility between January 6-10, 2020


Rashmi Pratap
December 13, 2019
The market is witnessing two dichotomies right now - one, the economy is showing signs of slowdown while markets are rising; and within markets, while top 15 companies are driving the Sensex and the Nifty, mid-caps and small-caps are being battered


BusinessToday.In
New Delhi, November 12, 2019
The deal proceeds will be utilised to strengthen Lupin's balance sheet as well as provide growth capital to support organic and inorganic initiatives for our focus markets, says Lupin CEO Vinita Gupta


PB Jayakumar
New Delhi, November 7, 2019
Lupin's net sales for the quarter stood at Rs 4,296 crore, an increase of 10.4 per cent compared to Rs 3,890 crore in the Q2FY19. The company posted a net loss of Rs 127 crore (after exceptional items) in Q2FY20, compared to Rs 266 crore net profit during the same quarter of the previous year


PTI
October 3, 2019
\"Sreeji brings to Lupin over 20 years of significant domain expertise and global experience,\" Lupin said in a statement


PB Jayakumar
New Delhi, September 4, 2019
Boehringer Ingelheim and Lupin will jointly develop Lupin's candidate cancer compound (LNP3794) as a potential targeted therapy for patients with difficult-to-treat cancers like pancreatic, colorectal, lung cancer, skin cancer etc.


PTI
August 7, 2019
Drug firm Lupin on Wednesday reported a 49.46 per cent rise in consolidated net profit to Rs 303.05 crore for the quarter ended June 30, 2019 on account of robust sales in India and overseas.


E Kumar Sharma
New Delhi, July 24, 2019
Analysts expect a better show in Q1 thanks to a combination of factors such as overall business improvement in the Unites States and a pick-up in demand in the domestic market.


PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


BusinessToday.In
New Delhi, May 30, 2019
Swaraj, 66, who underwent a kidney transplant in December 2016, had decided to not contest the Lok Sabha elections due to health reasons


BusinessToday.In
New Delhi, May 15, 2019
Net profit after exceptional items was up 141.4 per cent at Rs 606.60 crore during the financial year ended March 31, 2019; sales for Q4 FY2019 were up 8.7 per cent at Rs 4,325.90 crore compared to Rs 3,978.50 crore in Q4 FY2018;


PTI
May 15, 2019



BusinessToday.In
April 12, 2019
Former Air Force chief NC Suri told India Today that he had not signed any such letter. In fact, Air Marshall Suri has written another letter to the President's office clarifying his stance. General SF Rodrigues said he had no idea about the letter and called it fake.


PTI
April 3, 2019



PTI
April 2, 2019



PTI
March 27, 2019



PTI
March 26, 2019



PAGES 1 OF 4  1234